0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Generalized Anxiety Disorder Treatment Market Research Report 2023
Published Date: September 2023
|
Report Code: QYRE-Auto-25J13657
Home | Market Reports | Health| Mental Health| Anxiety & Stress
Global Generalized Anxiety Disorder Treatment Market Research Report 2023
BUY CHAPTERS

Global Generalized Anxiety Disorder Treatment Market Research Report 2023

Code: QYRE-Auto-25J13657
Report
September 2023
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Generalized Anxiety Disorder Treatment Market Size

According to new survey, global Generalized Anxiety Disorder Treatment market is projected to reach US$ 9411.9 million in 2029, increasing from US$ 5152 million in 2022, with the CAGR of 9.0% during the period of 2023 to 2029.

Generalized Anxiety Disorder Treatment Market

Generalized Anxiety Disorder Treatment Market

The two main treatments for generalized anxiety disorder are psychotherapy and medications. You may benefit most from a combination of the two. It may take some trial and error to discover which treatments work best for you.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Generalized Anxiety Disorder Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Generalized Anxiety Disorder Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Generalized Anxiety Disorder Treatment Market Report

Report Metric Details
Report Name Generalized Anxiety Disorder Treatment Market
Accounted market size in 2022 US$ 5152 million
Forecasted market size in 2029 US$ 9411.9 million
CAGR 9.0%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • SSRIs
  • SNRIs
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Generalized Anxiety Disorder Treatment Market growing?

Ans: The Generalized Anxiety Disorder Treatment Market witnessing a CAGR of 9.0% during the forecast period 2023-2029.

What is the Generalized Anxiety Disorder Treatment Market size in 2029?

Ans: The Generalized Anxiety Disorder Treatment Market size in 2029 will be US$ 9411.9 million.

Who are the main players in the Generalized Anxiety Disorder Treatment Market report?

Ans: The main players in the Generalized Anxiety Disorder Treatment Market are Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI

What are the Application segmentation covered in the Generalized Anxiety Disorder Treatment Market report?

Ans: The Applications covered in the Generalized Anxiety Disorder Treatment Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Generalized Anxiety Disorder Treatment Market report?

Ans: The Types covered in the Generalized Anxiety Disorder Treatment Market report are SSRIs, SNRIs, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generalized Anxiety Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Generalized Anxiety Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generalized Anxiety Disorder Treatment Market Perspective (2018-2029)
2.2 Generalized Anxiety Disorder Treatment Growth Trends by Region
2.2.1 Global Generalized Anxiety Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Generalized Anxiety Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Generalized Anxiety Disorder Treatment Forecasted Market Size by Region (2024-2029)
2.3 Generalized Anxiety Disorder Treatment Market Dynamics
2.3.1 Generalized Anxiety Disorder Treatment Industry Trends
2.3.2 Generalized Anxiety Disorder Treatment Market Drivers
2.3.3 Generalized Anxiety Disorder Treatment Market Challenges
2.3.4 Generalized Anxiety Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generalized Anxiety Disorder Treatment Players by Revenue
3.1.1 Global Top Generalized Anxiety Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Generalized Anxiety Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Generalized Anxiety Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generalized Anxiety Disorder Treatment Revenue
3.4 Global Generalized Anxiety Disorder Treatment Market Concentration Ratio
3.4.1 Global Generalized Anxiety Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generalized Anxiety Disorder Treatment Revenue in 2022
3.5 Generalized Anxiety Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Generalized Anxiety Disorder Treatment Product Solution and Service
3.7 Date of Enter into Generalized Anxiety Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generalized Anxiety Disorder Treatment Breakdown Data by Type
4.1 Global Generalized Anxiety Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Type (2024-2029)
5 Generalized Anxiety Disorder Treatment Breakdown Data by Application
5.1 Global Generalized Anxiety Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Generalized Anxiety Disorder Treatment Market Size (2018-2029)
6.2 North America Generalized Anxiety Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generalized Anxiety Disorder Treatment Market Size (2018-2029)
7.2 Europe Generalized Anxiety Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generalized Anxiety Disorder Treatment Market Size (2018-2029)
8.2 Asia-Pacific Generalized Anxiety Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Generalized Anxiety Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Generalized Anxiety Disorder Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generalized Anxiety Disorder Treatment Market Size (2018-2029)
9.2 Latin America Generalized Anxiety Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generalized Anxiety Disorder Treatment Market Size (2018-2029)
10.2 Middle East & Africa Generalized Anxiety Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intellipharmaceutics
11.1.1 Intellipharmaceutics Company Detail
11.1.2 Intellipharmaceutics Business Overview
11.1.3 Intellipharmaceutics Generalized Anxiety Disorder Treatment Introduction
11.1.4 Intellipharmaceutics Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.1.5 Intellipharmaceutics Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Generalized Anxiety Disorder Treatment Introduction
11.2.4 Pfizer Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Generalized Anxiety Disorder Treatment Introduction
11.3.4 Eli Lilly Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Astrazeneca
11.4.1 Astrazeneca Company Detail
11.4.2 Astrazeneca Business Overview
11.4.3 Astrazeneca Generalized Anxiety Disorder Treatment Introduction
11.4.4 Astrazeneca Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.4.5 Astrazeneca Recent Development
11.5 Lundbeck
11.5.1 Lundbeck Company Detail
11.5.2 Lundbeck Business Overview
11.5.3 Lundbeck Generalized Anxiety Disorder Treatment Introduction
11.5.4 Lundbeck Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.5.5 Lundbeck Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Generalized Anxiety Disorder Treatment Introduction
11.6.4 Allergan Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.6.5 Allergan Recent Development
11.7 GSK
11.7.1 GSK Company Detail
11.7.2 GSK Business Overview
11.7.3 GSK Generalized Anxiety Disorder Treatment Introduction
11.7.4 GSK Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.7.5 GSK Recent Development
11.8 Otsuka Pharmaceutical
11.8.1 Otsuka Pharmaceutical Company Detail
11.8.2 Otsuka Pharmaceutical Business Overview
11.8.3 Otsuka Pharmaceutical Generalized Anxiety Disorder Treatment Introduction
11.8.4 Otsuka Pharmaceutical Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.8.5 Otsuka Pharmaceutical Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Generalized Anxiety Disorder Treatment Introduction
11.9.4 Takeda Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.9.5 Takeda Recent Development
11.10 NHU Group
11.10.1 NHU Group Company Detail
11.10.2 NHU Group Business Overview
11.10.3 NHU Group Generalized Anxiety Disorder Treatment Introduction
11.10.4 NHU Group Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.10.5 NHU Group Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Detail
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Generalized Anxiety Disorder Treatment Introduction
11.11.4 Shionogi Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.11.5 Shionogi Recent Development
11.12 APOTEX
11.12.1 APOTEX Company Detail
11.12.2 APOTEX Business Overview
11.12.3 APOTEX Generalized Anxiety Disorder Treatment Introduction
11.12.4 APOTEX Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.12.5 APOTEX Recent Development
11.13 Kanghong Pharma
11.13.1 Kanghong Pharma Company Detail
11.13.2 Kanghong Pharma Business Overview
11.13.3 Kanghong Pharma Generalized Anxiety Disorder Treatment Introduction
11.13.4 Kanghong Pharma Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.13.5 Kanghong Pharma Recent Development
11.14 HUAHAI
11.14.1 HUAHAI Company Detail
11.14.2 HUAHAI Business Overview
11.14.3 HUAHAI Generalized Anxiety Disorder Treatment Introduction
11.14.4 HUAHAI Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023)
11.14.5 HUAHAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Generalized Anxiety Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of SSRIs
    Table 3. Key Players of SNRIs
    Table 4. Key Players of Others
    Table 5. Global Generalized Anxiety Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Generalized Anxiety Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Generalized Anxiety Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Generalized Anxiety Disorder Treatment Market Share by Region (2018-2023)
    Table 9. Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Generalized Anxiety Disorder Treatment Market Share by Region (2024-2029)
    Table 11. Generalized Anxiety Disorder Treatment Market Trends
    Table 12. Generalized Anxiety Disorder Treatment Market Drivers
    Table 13. Generalized Anxiety Disorder Treatment Market Challenges
    Table 14. Generalized Anxiety Disorder Treatment Market Restraints
    Table 15. Global Generalized Anxiety Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Generalized Anxiety Disorder Treatment Market Share by Players (2018-2023)
    Table 17. Global Top Generalized Anxiety Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generalized Anxiety Disorder Treatment as of 2022)
    Table 18. Ranking of Global Top Generalized Anxiety Disorder Treatment Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Generalized Anxiety Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Generalized Anxiety Disorder Treatment Product Solution and Service
    Table 22. Date of Enter into Generalized Anxiety Disorder Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Generalized Anxiety Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Type (2018-2023)
    Table 26. Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Type (2024-2029)
    Table 28. Global Generalized Anxiety Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Application (2018-2023)
    Table 30. Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Application (2024-2029)
    Table 32. North America Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Intellipharmaceutics Company Detail
    Table 48. Intellipharmaceutics Business Overview
    Table 49. Intellipharmaceutics Generalized Anxiety Disorder Treatment Product
    Table 50. Intellipharmaceutics Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 51. Intellipharmaceutics Recent Development
    Table 52. Pfizer Company Detail
    Table 53. Pfizer Business Overview
    Table 54. Pfizer Generalized Anxiety Disorder Treatment Product
    Table 55. Pfizer Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 56. Pfizer Recent Development
    Table 57. Eli Lilly Company Detail
    Table 58. Eli Lilly Business Overview
    Table 59. Eli Lilly Generalized Anxiety Disorder Treatment Product
    Table 60. Eli Lilly Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 61. Eli Lilly Recent Development
    Table 62. Astrazeneca Company Detail
    Table 63. Astrazeneca Business Overview
    Table 64. Astrazeneca Generalized Anxiety Disorder Treatment Product
    Table 65. Astrazeneca Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 66. Astrazeneca Recent Development
    Table 67. Lundbeck Company Detail
    Table 68. Lundbeck Business Overview
    Table 69. Lundbeck Generalized Anxiety Disorder Treatment Product
    Table 70. Lundbeck Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 71. Lundbeck Recent Development
    Table 72. Allergan Company Detail
    Table 73. Allergan Business Overview
    Table 74. Allergan Generalized Anxiety Disorder Treatment Product
    Table 75. Allergan Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 76. Allergan Recent Development
    Table 77. GSK Company Detail
    Table 78. GSK Business Overview
    Table 79. GSK Generalized Anxiety Disorder Treatment Product
    Table 80. GSK Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 81. GSK Recent Development
    Table 82. Otsuka Pharmaceutical Company Detail
    Table 83. Otsuka Pharmaceutical Business Overview
    Table 84. Otsuka Pharmaceutical Generalized Anxiety Disorder Treatment Product
    Table 85. Otsuka Pharmaceutical Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 86. Otsuka Pharmaceutical Recent Development
    Table 87. Takeda Company Detail
    Table 88. Takeda Business Overview
    Table 89. Takeda Generalized Anxiety Disorder Treatment Product
    Table 90. Takeda Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 91. Takeda Recent Development
    Table 92. NHU Group Company Detail
    Table 93. NHU Group Business Overview
    Table 94. NHU Group Generalized Anxiety Disorder Treatment Product
    Table 95. NHU Group Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 96. NHU Group Recent Development
    Table 97. Shionogi Company Detail
    Table 98. Shionogi Business Overview
    Table 99. Shionogi Generalized Anxiety Disorder Treatment Product
    Table 100. Shionogi Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 101. Shionogi Recent Development
    Table 102. APOTEX Company Detail
    Table 103. APOTEX Business Overview
    Table 104. APOTEX Generalized Anxiety Disorder Treatment Product
    Table 105. APOTEX Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 106. APOTEX Recent Development
    Table 107. Kanghong Pharma Company Detail
    Table 108. Kanghong Pharma Business Overview
    Table 109. Kanghong Pharma Generalized Anxiety Disorder Treatment Product
    Table 110. Kanghong Pharma Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 111. Kanghong Pharma Recent Development
    Table 112. HUAHAI Company Detail
    Table 113. HUAHAI Business Overview
    Table 114. HUAHAI Generalized Anxiety Disorder Treatment Product
    Table 115. HUAHAI Revenue in Generalized Anxiety Disorder Treatment Business (2018-2023) & (US$ Million)
    Table 116. HUAHAI Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Generalized Anxiety Disorder Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Generalized Anxiety Disorder Treatment Market Share by Type: 2022 VS 2029
    Figure 3. SSRIs Features
    Figure 4. SNRIs Features
    Figure 5. Others Features
    Figure 6. Global Generalized Anxiety Disorder Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Generalized Anxiety Disorder Treatment Market Share by Application: 2022 VS 2029
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Generalized Anxiety Disorder Treatment Report Years Considered
    Figure 12. Global Generalized Anxiety Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Generalized Anxiety Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Generalized Anxiety Disorder Treatment Market Share by Region: 2022 VS 2029
    Figure 15. Global Generalized Anxiety Disorder Treatment Market Share by Players in 2022
    Figure 16. Global Top Generalized Anxiety Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generalized Anxiety Disorder Treatment as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Generalized Anxiety Disorder Treatment Revenue in 2022
    Figure 18. North America Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Generalized Anxiety Disorder Treatment Market Share by Country (2018-2029)
    Figure 20. United States Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Generalized Anxiety Disorder Treatment Market Share by Country (2018-2029)
    Figure 24. Germany Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Generalized Anxiety Disorder Treatment Market Share by Region (2018-2029)
    Figure 32. China Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Generalized Anxiety Disorder Treatment Market Share by Country (2018-2029)
    Figure 40. Mexico Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Generalized Anxiety Disorder Treatment Market Share by Country (2018-2029)
    Figure 44. Turkey Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Intellipharmaceutics Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 47. Pfizer Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 48. Eli Lilly Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 49. Astrazeneca Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 50. Lundbeck Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 51. Allergan Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 52. GSK Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 54. Takeda Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 55. NHU Group Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 56. Shionogi Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 57. APOTEX Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 58. Kanghong Pharma Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 59. HUAHAI Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS